{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T22:35:58Z","timestamp":1793140558088,"version":"4.5.0"},"reference-count":61,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Cardiol"],"published-print":{"date-parts":[[2021,4,1]]},"DOI":"10.1001\/jamacardio.2020.7073","type":"journal-article","created":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T11:32:13Z","timestamp":1611142333000},"page":"437","source":"Crossref","is-referenced-by-count":168,"title":["Association of Lipid, Inflammatory, and Metabolic Biomarkers With Age at Onset for Incident Coronary Heart Disease in Women"],"prefix":"10.1001","volume":"6","author":[{"given":"Sagar B.","family":"Dugani","sequence":"first","affiliation":[{"name":"Center for Lipid Metabolomics, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Hospital Internal Medicine, Mayo Clinic, Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Vinayaga","family":"Moorthy","sequence":"additional","affiliation":[{"name":"Center for Lipid Metabolomics, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunying","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Lipid Metabolomics, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga V.","family":"Demler","sequence":"additional","affiliation":[{"name":"Center for Lipid Metabolomics, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alawi A.","family":"Alsheikh-Ali","sequence":"additional","affiliation":[{"name":"College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Ridker","sequence":"additional","affiliation":[{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J.","family":"Glynn","sequence":"additional","affiliation":[{"name":"Center for Lipid Metabolomics, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Mora","sequence":"additional","affiliation":[{"name":"Center for Lipid Metabolomics, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Preventive Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"},{"name":"Division of Cardiovascular Medicine, Brigham and Women\u2019s Hospital, Harvard Medical School, Boston, Massachusetts"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"14","key":"hoi200091r1","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1056\/NEJMra1109345","article-title":"Noncommunicable diseases.","volume":"369","author":"Hunter","year":"2013","journal-title":"N Engl J Med"},{"issue":"3","key":"hoi200091r2","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0195-668X(02)00386-X","article-title":"Screening of family members of patients with premature coronary heart disease; results from the EUROASPIRE II family survey.","volume":"24","author":"De Sutter","year":"2003","journal-title":"Eur Heart J"},{"issue":"2","key":"hoi200091r3","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1097\/HJR.0b013e3283294b1d","article-title":"EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries.","volume":"16","author":"Kotseva","year":"2009","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"18","key":"hoi200091r4","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1001\/jama.291.18.2204","article-title":"Parental cardiovascular disease as a risk factor for cardiovascular disease in middle-aged adults: a prospective study of parents and offspring.","volume":"291","author":"Lloyd-Jones","year":"2004","journal-title":"JAMA"},{"issue":"11","key":"hoi200091r5","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1161\/CIRCULATIONAHA.115.015293","article-title":"Coronary heart disease mortality declines in the United States from 1979 through 2011.","volume":"132","author":"Wilmot","year":"2015","journal-title":"Circulation"},{"issue":"12","key":"hoi200091r6","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.annepidem.2017.10.012","article-title":"Widespread recent increases in county-level heart disease mortality across age groups.","volume":"27","author":"Vaughan","year":"2017","journal-title":"Ann Epidemiol"},{"issue":"5","key":"hoi200091r7","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1161\/CIRCOUTCOMES.110.960005","article-title":"Age- and sex-specific trends in the incidence of hospitalized acute coronary syndromes in Western Australia.","volume":"4","author":"Nedkoff","year":"2011","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"hoi200091r8","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1089\/jwh.2013.4507","article-title":"Do younger women fare worse? sex differences in acute myocardial infarction hospitalization and early mortality rates over ten years.","volume":"23","author":"Izadnegahdar","year":"2014","journal-title":"J Womens Health (Larchmt)"},{"issue":"1","key":"hoi200091r9","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/1471-2458-8-148","article-title":"Patterns of coronary heart disease mortality over the 20th century in England and Wales: possible plateaus in the rate of decline.","volume":"8","author":"Allender","year":"2008","journal-title":"BMC Public Health"},{"issue":"4","key":"hoi200091r10","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1038\/nrcardio.2017.154","article-title":"Epidemiology of cardiovascular disease in young individuals.","volume":"15","author":"Andersson","year":"2018","journal-title":"Nat Rev Cardiol"},{"issue":"7","key":"hoi200091r11","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1177\/2048872616661847","article-title":"Sex differences in young patients with acute myocardial infarction: a VIRGO study analysis.","volume":"6","author":"Bucholz","year":"2017","journal-title":"Eur Heart J Acute Cardiovasc Care"},{"issue":"7","key":"hoi200091r12","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1503\/cmaj.131450","article-title":"Sex-related differences in access to care among patients with premature acute coronary syndrome.","volume":"186","author":"Pelletier","year":"2014","journal-title":"CMAJ"},{"issue":"11","key":"hoi200091r13","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1001\/jamainternmed.2014.4762","article-title":"Sex differences in short-term and long-term all-cause mortality among patients with ST-segment elevation myocardial infarction treated by primary percutaneous intervention: a meta-analysis.","volume":"174","author":"Pancholy","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"18","key":"hoi200091r14","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1016\/j.jacc.2015.08.865","article-title":"Temporal trends and sex differences in revascularization and outcomes of ST-segment elevation myocardial infarction in younger adults in the United States.","volume":"66","author":"Khera","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"hoi200091r15","doi-asserted-by":"publisher","first-page":"1587","DOI":"10.1136\/heartjnl-2017-311429","article-title":"Sex differences in risk factor management of coronary heart disease across three regions.","volume":"103","author":"Zhao","year":"2017","journal-title":"Heart"},{"issue":"9438","key":"hoi200091r16","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","article-title":"Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.","volume":"364","author":"Yusuf","year":"2004","journal-title":"Lancet"},{"issue":"3","key":"hoi200091r17","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.jacc.2017.11.007","article-title":"Cardiovascular risk and statin eligibility of young adults after an MI: Partners YOUNG-MI registry.","volume":"71","author":"Singh","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"hoi200091r18","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.ahj.2004.06.003","article-title":"Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE).","volume":"149","author":"Avezum","year":"2005","journal-title":"Am Heart J"},{"issue":"9","key":"hoi200091r19","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1161\/CIRCULATIONAHA.114.013116","article-title":"Metabolite profiling and cardiovascular event risk: a prospective study of 3 population-based cohorts.","volume":"131","author":"W\u00fcrtz","year":"2015","journal-title":"Circulation"},{"issue":"18","key":"hoi200091r20","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.113.002500","article-title":"Lipidomics profiling and risk of cardiovascular disease in the prospective population-based Bruneck study.","volume":"129","author":"Stegemann","year":"2014","journal-title":"Circulation"},{"issue":"11","key":"hoi200091r21","doi-asserted-by":"publisher","first-page":"742","DOI":"10.7326\/0003-4819-155-11-201112060-00006","article-title":"Association of high-density lipoprotein cholesterol with incident cardiovascular events in women, by low-density lipoprotein cholesterol and apolipoprotein B100 levels: a cohort study.","volume":"155","author":"Mora","year":"2011","journal-title":"Ann Intern Med"},{"issue":"7","key":"hoi200091r22","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1161\/CIRCULATIONAHA.108.816181","article-title":"Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.","volume":"119","author":"Mora","year":"2009","journal-title":"Circulation"},{"issue":"5","key":"hoi200091r23","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1161\/CIRCULATIONAHA.113.005873","article-title":"Discordance of low-density lipoprotein (LDL) cholesterol with alternative LDL-related measures and future coronary events.","volume":"129","author":"Mora","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"hoi200091r24","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1016\/j.jacc.2017.12.006","article-title":"Lipids, lipoproteins, and metabolites and risk of myocardial infarction and stroke.","volume":"71","author":"Holmes","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"hoi200091r25","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.118.002157","article-title":"Circulating branched-chain amino acids and incident cardiovascular disease in a prospective cohort of US women.","volume":"11","author":"Tobias","year":"2018","journal-title":"Circ Genom Precis Med"},{"issue":"7","key":"hoi200091r26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003822","article-title":"Circulating N-linked glycoprotein side-chain biomarker, rosuvastatin therapy, and incident cardiovascular disease: an analysis from the JUPITER Trial.","volume":"5","author":"Akinkuolie","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"hoi200091r27","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1161\/CIRCOUTCOMES.113.000675","article-title":"High-density lipoprotein particle subclass heterogeneity and incident coronary heart disease.","volume":"7","author":"Akinkuolie","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"13","key":"hoi200091r28","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women.","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"issue":"1","key":"hoi200091r29","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.294.1.56","article-title":"Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women\u2019s Health Study: a randomized controlled trial.","volume":"294","author":"Lee","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"hoi200091r30","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1001\/jama.294.1.47","article-title":"Low-dose aspirin in the primary prevention of cancer: the Women\u2019s Health Study: a randomized controlled trial.","volume":"294","author":"Cook","year":"2005","journal-title":"JAMA"},{"issue":"2","key":"hoi200091r32","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1001\/jamacardio.2016.0096","article-title":"Association of lipoproteins, insulin resistance, and rosuvastatin with incident type 2 diabetes mellitus: secondary analysis of a randomized clinical trial.","volume":"1","author":"Dugani","year":"2016","journal-title":"JAMA Cardiol"},{"issue":"6","key":"hoi200091r33","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"issue":"6","key":"hoi200091r34","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1001\/jama.297.6.611","article-title":"Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds Risk Score.","volume":"297","author":"Ridker","year":"2007","journal-title":"JAMA"},{"issue":"7","key":"hoi200091r35","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1161\/CIRCRESAHA.115.308078","article-title":"Circulating N-linked glycoprotein acetyls and longitudinal mortality risk.","volume":"118","author":"Lawler","year":"2016","journal-title":"Circ Res"},{"issue":"5","key":"hoi200091r36","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.001221","article-title":"A novel protein glycan biomarker and future cardiovascular disease events.","volume":"3","author":"Akinkuolie","year":"2014","journal-title":"J Am Heart Assoc"},{"issue":"6","key":"hoi200091r37","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1161\/ATVBAHA.115.305635","article-title":"Novel protein glycan side-chain biomarker and risk of incident type 2 diabetes mellitus.","volume":"35","author":"Akinkuolie","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"hoi200091r38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0165615","article-title":"Association of N-linked glycoprotein acetyls and colorectal cancer incidence and mortality.","volume":"11","author":"Chandler","year":"2016","journal-title":"PLoS One"},{"issue":"10","key":"hoi200091r39","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1093\/aje\/kwi309","article-title":"Comparison of risk factors for the competing risks of coronary heart disease, stroke, and venous thromboembolism.","volume":"162","author":"Glynn","year":"2005","journal-title":"Am J Epidemiol"},{"issue":"3","key":"hoi200091r40","first-page":"531","article-title":"The occurrence of lung cancer in man.","volume":"9","author":"Levin","year":"1953","journal-title":"Acta Unio Int Contra Cancrum"},{"issue":"4","key":"hoi200091r41","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1159\/000095421","article-title":"Characteristics and outcome of acute myocardial infarction in young patients. the PRIAMHO II study.","volume":"107","author":"Morillas","year":"2007","journal-title":"Cardiology"},{"issue":"9765","key":"hoi200091r42","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9\u00b71 million participants.","volume":"377","author":"Finucane","year":"2011","journal-title":"Lancet"},{"issue":"2","key":"hoi200091r43","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.jcdr.2012.08.005","article-title":"Age and clinical outcomes in patients presenting with acute coronary syndromes.","volume":"4","author":"Ahmed","year":"2013","journal-title":"J Cardiovasc Dis Res"},{"issue":"8","key":"hoi200091r44","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1001\/archinte.1997.00440290049005","article-title":"Epidemiologic variables and outcome of 1972 young patients with acute myocardial infarction: data from the GISSI-2 database. Investigators of the Gruppo Italiano per lo Studio della Sopravvivenza nell\u2019Infarto Miocardico (GISSI-2).","volume":"157","author":"Moccetti","year":"1997","journal-title":"Arch Intern Med"},{"issue":"6","key":"hoi200091r45","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1111\/j.1365-2362.2011.02629.x","article-title":"Relative importance of different lipid risk factors for the development of myocardial infarction at a very young age (=40 years of age).","volume":"42","author":"Goliasch","year":"2012","journal-title":"Eur J Clin Invest"},{"issue":"6","key":"hoi200091r46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jacl.2015.08.009","article-title":"Premature myocardial infarction is strongly associated with increased levels of remnant cholesterol.","volume":"9","author":"Goliasch","year":"2015","journal-title":"J Clin Lipidol"},{"issue":"6","key":"hoi200091r47","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.jacl.2014.09.006","article-title":"Age- and sex-related difference in lipid profiles of patients hospitalized with acute myocardial infarction in East China.","volume":"8","author":"Wei","year":"2014","journal-title":"J Clin Lipidol"},{"issue":"10","key":"hoi200091r48","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.116.003665","article-title":"Age and cardiovascular risk attributable to apolipoprotein B, low-density lipoprotein cholesterol or non-high-density lipoprotein cholesterol.","volume":"5","author":"Sniderman","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"17","key":"hoi200091r49","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/j.jacc.2011.12.035","article-title":"On-treatment non\u2013high-density lipoprotein cholesterol, apolipoprotein B, triglycerides, and lipid ratios in relation to residual vascular risk after treatment with potent statin therapy: JUPITER (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin).","volume":"59","author":"Mora","year":"2012","journal-title":"J Am Coll Cardiol"},{"issue":"11","key":"hoi200091r50","doi-asserted-by":"publisher","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.113.002671","article-title":"High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy.","volume":"128","author":"Mora","year":"2013","journal-title":"Circulation"},{"issue":"1","key":"hoi200091r51","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.atherosclerosis.2006.05.007","article-title":"LDL particle subclasses, LDL particle size, and carotid atherosclerosis in the Multi-Ethnic Study of Atherosclerosis (MESA).","volume":"192","author":"Mora","year":"2007","journal-title":"Atherosclerosis"},{"issue":"12","key":"hoi200091r52","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease.","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"issue":"4","key":"hoi200091r53","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/CIRCRESAHA.116.310527","article-title":"How common is residual inflammatory risk?","volume":"120","author":"Ridker","year":"2017","journal-title":"Circ Res"},{"issue":"27","key":"hoi200091r54","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease.","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"hoi200091r55","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1161\/CIRCRESAHA.115.306656","article-title":"From C-reactive protein to interleukin-6 to interleukin-1: moving upstream to identify novel targets for atheroprotection.","volume":"118","author":"Ridker","year":"2016","journal-title":"Circ Res"},{"issue":"5","key":"hoi200091r56","doi-asserted-by":"publisher","first-page":"1257","DOI":"10.1016\/j.jacl.2017.06.008","article-title":"Lipoprotein insulin resistance score and risk of incident diabetes during extended follow-up of 20 years: the Women\u2019s Health Study.","volume":"11","author":"Harada","year":"2017","journal-title":"J Clin Lipidol"},{"issue":"8","key":"hoi200091r57","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1089\/met.2014.0050","article-title":"Lipoprotein insulin resistance index: a lipoprotein particle-derived measure of insulin resistance.","volume":"12","author":"Shalaurova","year":"2014","journal-title":"Metab Syndr Relat Disord"},{"issue":"1","key":"hoi200091r58","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1001\/jama.290.1.86","article-title":"Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review.","volume":"290","author":"Critchley","year":"2003","journal-title":"JAMA"},{"issue":"1","key":"hoi200091r59","doi-asserted-by":"publisher","first-page":"96","DOI":"10.2105\/AJPH.2012.301091","article-title":"Smoking and risk of coronary heart disease in younger, middle-aged, and older adults.","volume":"104","author":"Tolstrup","year":"2014","journal-title":"Am J Public Health"},{"issue":"13","key":"hoi200091r60","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1161\/CIRCULATIONAHA.117.031855","article-title":"Quantifying importance of major risk factors for coronary heart disease.","volume":"139","author":"Pencina","year":"2019","journal-title":"Circulation"},{"issue":"10152","key":"hoi200091r61","doi-asserted-by":"publisher","first-page":"1072","DOI":"10.1016\/S0140-6736(18)31992-5","article-title":"NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4.","volume":"392","author":"Bennett","year":"2018","journal-title":"Lancet"},{"key":"hoi200091r31","unstructured":"Women\u2019s Health Study (WHS). A Randomized Trial of Low-Dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer. ClinicalTrials.gov identifier: NCT00000479. Updated June 15, 2012. Accessed November 1, 2019. https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT00000479"}],"container-title":["JAMA Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/articlepdf\/2775559\/jamacardiology_dugani_2021_oi_200091_1617381063.26688.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T14:09:38Z","timestamp":1618236578000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamacardiology\/fullarticle\/2775559"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,1]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamacardio.2020.7073","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.739398604.793585289","asserted-by":"object"}]},"ISSN":["2380-6583"],"issn-type":[{"value":"2380-6583","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4,1]]}}}